Cardiogenic shock belongs to the most severe and immediately life-threatening complications of the acutemyocardial
infarction. Despite development of modern diagnostic and therapeutic methods the incidence and mortality of
cardiogenic shock has not significantly declined in the past decades. Early reperfusion strategy with percutaneous
revascularization has become a cornerstone of therapy. The complex approach to cardiogenic shock comprises
pharmacological and mechanical hemodynamic support, ventilatory support utilizing new ventilator regimens,
metabolic and renal support/replacement with continuous renal replacement therapies and psychological, eventually
psychopharmacological support. All these measures enable prevention of the multiple organ failure syndrome
development and positively influence high mortality of patients suffering from cardiogenic shock.
cardiogenic shock, acute myocardial infarction, reperfusion therapy.